![[Feedback]](/icons/banner/feedbackACT.gif){kind=icon}
![[For Subscribers]](/icons/banner/subscriberACT.gif){kind=icon}
![[Archive]](/icons/banner/archiveACT.gif){kind=icon}
![[Search]](/icons/banner/searchACT.gif){kind=icon}
![[Contents]](/icons/banner/tocACT.gif){kind=icon}
|
|
|
|
|
||
A Dumuis, R Bouhelal, M Sebben, R Cory and J Bockaert
Centre CNRS-INSERM de Pharmacologie Endocrinologie, Montpellier, France.
A nonclassical 5-hydroxytryptamine (5-HT) receptor mediates the stimulation of adenylate cyclase activity in mouse embryo colliculi neurons in primary culture. The pharmacological profile characterized with agonists and antagonists suggests that this 5-HT receptor does not appear to correspond to a known 5-HT receptor. On this 5-HT receptor, 5- HT (EC50 = 109 +/- 17 nM) and 5-methoxytryptamine (5-MeOT) were equipotent agonists. The other tryptamine derivatives, 5- carboxamidotryptamine (5-CT) and 5-methoxy-N,N-dimethyltryptamine (5- MeOT-N,N-DMT), were full potent agonists, whereas tryptamine, bufotenine, and 2-CH3-5-HT were weak partial agonists. Two selective 5- HT1A agonists: 8-hydroxy-2-(di-n-propylamino)-tetralin (8-OH-DPAT) and ipsapirone, could not stimulate adenylate cyclase. RU 24969, a tetrahydropyridoindole derivative that is a potent 5-HT1A and 5-HT1B agonist was also inactive, whereas RU 28253, another member of this series, could stimulate cAMP production. The action of antagonists acting on 5-HT1 or 5-HT2 receptors, such as methiothepin (5-HT1 and 5- HT2), metergoline (5-HT1 and 5-HT2), spiperone (5-HT1A and 5-HT2), (-)- pindolol (5-HT1B), mesulergine (5-HT1C), and ketanserin (5-HT2), were almost inactive in reversing the 5-HT stimulating effect. The selective 5-HT3 antagonist ICS 205 930 was a full competitive antagonist at this receptor. Nevertheless, MDL 72222, which is also a 5-HT3 antagonist, was very weak in antagonizing the 5-HT stimulatory effect. A receptor with similar characteristics has also been found in guinea pig hippocampal membranes. In these membranes, the second receptor of low affinity for 5-HT, termed RL, which is positively coupled to adenylate cyclase, was also antagonized by ICS 205 930. The relatively low affinity of this hippocampal receptor for 5-CT, its stimulation by RU 28253 but not by RU 24969, and its previously reported pharmacological characteristics support the contention that this 5-HT receptor and the 5-HT receptor of mouse embryo colliculi neurons in primary culture (both positively coupled to cAMP formation) present great homologies. Inasmuch as none of the classical specific 5-HT1 and 5-HT2 agonists or antagonists interact with these 5-HT receptors, it is unlikely that they belong to 5-HT1 or 5-HT2 receptor categories.(ABSTRACT TRUNCATED AT 400 WORDS)
This article has been cited by other articles:
|
|
 |
|
  J. H. De Maeyer, J. Aerssens, P. Verhasselt, and R. A. Lefebvre Alternative splicing and exon duplication generates 10 unique porcine 5-HT4 receptor splice variants including a functional homofusion variant Physiol Genomics, June 10, 2008; 34(1): 22 - 33. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Jean, G. Conductier, C. Manrique, C. Bouras, P. Berta, R. Hen, Y. Charnay, J. Bockaert, and V. Compan Anorexia induced by activation of serotonin 5-HT4 receptors is mediated by increases in CART in the nucleus accumbens PNAS, October 9, 2007; 104(41): 16335 - 16340. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. Wada, L. Hu, N. Mores, C. E. Navarro, H. Fuda, L. Z. Krsmanovic, and K. J. Catt Serotonin (5-HT) Receptor Subtypes Mediate Specific Modes of 5-HT-Induced Signaling and Regulation of Neurosecretion in Gonadotropin-Releasing Hormone Neurons Mol. Endocrinol., January 1, 2006; 20(1): 125 - 135. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. Barthet, F. Gaven, B. Framery, K. Shinjo, T. Nakamura, S. Claeysen, J. Bockaert, and A. Dumuis Uncoupling and Endocytosis of 5-Hydroxytryptamine 4 Receptors: DISTINCT MOLECULAR EVENTS WITH DIFFERENT GRK2 REQUIREMENTS J. Biol. Chem., July 29, 2005; 280(30): 27924 - 27934. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. Ponimaskin, A. Dumuis, F. Gaven, G. Barthet, M. Heine, K. Glebov, D. W. Richter, and M. Oppermann Palmitoylation of the 5-Hydroxytryptamine4a Receptor Regulates Receptor Phosphorylation, Desensitization, and {beta}-Arrestin-Mediated Endocytosis Mol. Pharmacol., May 1, 2005; 67(5): 1434 - 1443. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. Joubert, B. Hanson, G. Barthet, M. Sebben, S. Claeysen, W. Hong, P. Marin, A. Dumuis, and J. Bockaert New sorting nexin (SNX27) and NHERF specifically interact with the 5-HT4(a) receptor splice variant: roles in receptor targeting J. Cell Sci., October 15, 2004; 117(22): 5367 - 5379. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. R. Hayes, R. L. Moore, S. M. Shah, and M. Covasa 5-HT3 receptors participate in CCK-induced suppression of food intake by delaying gastric emptying Am J Physiol Regulatory Integrative Comp Physiol, October 1, 2004; 287(4): R817 - R823. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 V. Compan, M. Zhou, R. Grailhe, R. A. Gazzara, R. Martin, J. Gingrich, A. Dumuis, D. Brunner, J. Bockaert, and R. Hen Attenuated Response to Stress and Novelty and Hypersensitivity to Seizures in 5-HT4 Receptor Knock-Out Mice J. Neurosci., January 14, 2004; 24(2): 412 - 419. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. Cao, J. H. Han, S. Z. Kim, K. W. Cho, and S. H. Kim Diverse regulation of atrial natriuretic peptide secretion by serotonin receptor subtypes Cardiovasc Res, August 1, 2003; 59(2): 360 - 368. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Claeysen, L. Joubert, M. Sebben, J. Bockaert, and A. Dumuis A Single Mutation in the 5-HT4 Receptor (5-HT4-R D100(3.32)A) Generates a Gs-coupled Receptor Activated Exclusively by Synthetic Ligands (RASSL) J. Biol. Chem., January 3, 2003; 278(2): 699 - 702. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. Joubert, S. Claeysen, M. Sebben, A.-S. Bessis, R. D. Clark, R. S. Martin, J. Bockaert, and A. Dumuis A 5-HT4 Receptor Transmembrane Network Implicated in the Activity of Inverse Agonists but Not Agonists J. Biol. Chem., July 5, 2002; 277(28): 25502 - 25511. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Pindon, G. van Hecke, P. van Gompel, A. S. Lesage, J. E. Leysen, and M. Jurzak Differences in Signal Transduction of Two 5-HT4 Receptor Splice Variants: Compound Specificity and Dual Coupling with Galpha s- and Galpha i/o-Proteins Mol. Pharmacol., January 1, 2002; 61(1): 85 - 96. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. M. Cardenas, C. G. Cardenas, and R. S. Scroggs 5HT Increases Excitability of Nociceptor-Like Rat Dorsal Root Ganglion Neurons Via cAMP-Coupled TTX-Resistant Na+ Channels J Neurophysiol, July 1, 2001; 86(1): 241 - 248. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Claeysen, M. Sebben, C. Bécamel, R. M. Eglen, R. D. Clark, J. Bockaert, and A. Dumuis Pharmacological Properties of 5-Hydroxytryptamine4 Receptor Antagonists on Constitutively Active Wild-Type and Mutated Receptors Mol. Pharmacol., July 1, 2000; 58(1): 136 - 144. [Abstract] [Full Text]
|
|
|
|
|
|
U. E. Petaja-Repo, M. Hogue, A. Laperriere, P. Walker, and M. Bouvier Export from the Endoplasmic Reticulum Represents the Limiting Step in the Maturation and Cell Surface Expression of the Human delta Opioid Receptor J. Biol. Chem., April 28, 2000; 275(18): 13727 - 13736. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. Edwards and J. F. R. Paton 5-HT4 receptors in nucleus tractus solitarii attenuate cardiopulmonary reflex in anesthetized rats Am J Physiol Heart Circ Physiol, November 1, 1999; 277(5): H1914 - H1923. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. Pineyro and P. Blier Autoregulation of Serotonin Neurons: Role in Antidepressant Drug Action Pharmacol. Rev., September 1, 1999; 51(3): 533 - 591. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Claeysen, M. Sebben, C. Becamel, J. Bockaert, and A. Dumuis Novel Brain-Specific 5-HT4 Receptor Splice Variants Show Marked Constitutive Activity: Role of the C-Terminal Intracellular Domain Mol. Pharmacol., May 1, 1999; 55(5): 910 - 920. [Abstract] [Full Text]
|
|
|
|
 |
|
 N. Galeotti, C. Ghelardini, and A. Bartolini Role of 5-HT4 Receptors in the Mouse Passive Avoidance Test J. Pharmacol. Exp. Ther., September 1, 1998; 286(3): 1115 - 1121. [Abstract] [Full Text]
|
|
|
|
|
|
M. G. Giovannini, I. Ceccarelli, B. Molinari, M. Cecchi, J. Goldfarb, and P. Blandina Serotonergic Modulation of Acetylcholine Release from Cortex of Freely Moving Rats J. Pharmacol. Exp. Ther., June 1, 1998; 285(3): 1219 - 1225. [Abstract] [Full Text]
|
|
|
|
|
|
Y. Mine, T. Yoshikawa, S. Oku, R. Nagai, N. Yoshida, and K. Hosoki Comparison of Effect of Mosapride Citrate and Existing 5-HT4 Receptor Agonists on Gastrointestinal Motility In Vivo and In Vitro J. Pharmacol. Exp. Ther., December 1, 1997; 283(3): 1000 - 1008. [Abstract] [Full Text]
|
|
|
|
 |
|
 L. Sanders, J. A. Lynham, B. Bond, F. del Monte, S. E. Harding, and A. J. Kaumann Sensitization of Human Atrial 5-HT4 Receptors by Chronic ß-Blocker Treatment Circulation, November 1, 1995; 92(9): 2526 - 2539. [Abstract] [Full Text]
|
|
|
|
 |
|
 R. A. Prosser, R. R. Dean, D. M. Edgar, H. C. Heller, and J. D. Miller Serotonin and the Mammalian Circadian System: I. In Vitro Phase Shifts by Serotonergic Agonists and Antagonists J Biol Rhythms, April 1, 1993; 8(1): 1 - 16. [Abstract] [PDF]
|
|
|
|
|
|
E. G. Ponimaskin, M. Heine, L. Joubert, M. Sebben, U. Bickmeyer, D. W. Richter, and A. Dumuis The 5-Hydroxytryptamine(4a) Receptor Is Palmitoylated at Two Different Sites, and Acylation Is Critically Involved in Regulation of Receptor Constitutive Activity J. Biol. Chem., January 18, 2002; 277(4): 2534 - 2546. [Abstract] [Full Text] [PDF]
|
|
 |
 |
 |
|
 |
 |
 |
